The vasopressin market will exceed US $ 2,912.0 million by 2028,

0


[ad_1]

SEATTLE, Sept.27, 2021 (GLOBE NEWSWIRE) – According to Coherent Market Insights, the global vasopressin market is estimated at US $ 1,112.6 million in 2021 and is expected to post a CAGR of 14.7% during the forecast period (2021-2028).

Key trends and analysis of the global vasopressin market:

The Global vasopressin market is expected to experience significant growth, due to the increasing number of cardiovascular surgeries. For example, according to the Centers for Disease Control and Prevention (CDC), approximately 340,000 coronary artery bypass (CABG) procedures are performed each year in the United States. Therefore, the increasing number of cardiovascular surgeries is stimulating the demand for vasopressin to control blood flow.

Additionally, increasing vasopressin drug approvals are expected to drive the growth of the global vasopressin market. For example, in April 2018, Eagle Pharmaceuticals, Inc announced the approval of its Abbreviated New Drug Application (ANDA) for its 1ml injection of vasopressin. The product is an original generic version of the Vasostrict formulation from Endo International plc.

Request a copy of this report @ https://www.coherentmarketinsights.com/insight/request-sample/4646
Key points of the market:

Global Vasopressin Market Expected To Show A CAGR Of 14.7% during the forecast period (2021-2028), due to the increase in vasopressin drug launches. For example, in 2020, Dr Reddy’s Laboratories, a pharmaceutical company launched Desmopressin Acetate Injection USP, 4 mcg / mL in the US market. Desmopressin acetate is a synthetic analogue of the natural pituitary hormone 8-arginine vasopressin (ADH), an antidiuretic hormone affecting renal water retention.

North America is expected to be the most lucrative region in the vasopressin market, due to the presence of key players such as Par Pharmaceutical, Pfizer Inc, Fresenius Kabi Canada, and Cumberland Pharmaceuticals.

Competitive landscape:

The major players operating in the global vasopressin market are Par Pharmaceutical, Pfizer Inc., Novartis AG, Ferring Pharmaceuticals, Fresenius Kabi Canada, Astellas Pharma, Shanghai Soho-Yiming Pharmaceuticals, Endo International, Hybio Pharmaceutical, Hainan Zhonghe Pharmaceutical and Cumberland Pharmaceuticals .

Buy this research report now @ https://www.coherentmarketinsights.com/insight/buy-now/4646

Market segmentation :

  • Global Vasopressin Market, By Type:
    • Intravenous injection
    • Intramuscular injection
    • Subcutaneous injection
  • Global Vasopressin Market, By Application:
    • Anti-diuretic hormonal deficiency
    • Gastrointestinal bleeding
    • Vasodilator shock
    • Ventricular tachycardia and fibrillation
  • Global Vasopressin Market, By End User:
  • Global Vasopressin Market, By Region:
    • Latin America
      • By country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By country
        • Germany
        • UK
        • France
        • Italy
        • Spain
        • Russia
        • The rest of europe
    • Asia Pacific
      • By country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia-Pacific
    • Middle East
      • By country
        • CCG
        • Israel
        • Rest of the Middle East
    • Africa
      • By region / country
        • South Africa
        • central Africa
        • North Africa

Related Market Intelligence Reports:

U.S. Injectable Compounds Pharmacy Market, by Molecule (Acetaminophen, Phenylephrine, Midazolam, Esmolol, Vancomycin, Epinephrine, Adenocaine, Fentanyl / Bupivacaine, Morphine, Amiodarone, Fentanyl, Heparin, Ketamine, Dextrose, Hydromorphone, Lupidocaine (Bacivacaine, Bacivainol, Bacivacaine, Ketamine, Dextrose, Hydromorphone, Lupidocaine, Bacivaine, Bacivaine, Bacivacaine, Ketamine, Dextrose, Hydromorphone, Clonidine, Ketorolac), RKK (Ropivacaine, Ketorolac, Ketamine), Noradrenaline, Diltiazem, Vasopressin and others), by type of packaging (vials, ampoules, pre-filled syringes and others) and by type of pharmacy (503A Pharmacies and 503B Pharmacies) – Size, share, outlook and opportunity analysis, 2021 – 2028

Dextrose Injection Market, by product type (5% dextrose injection, 10% dextrose injection, 50% dextrose injection, 70% dextrose injection and others), by application (first aid treatment, sports, trophotherapy and others ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies) and By Region (North America, Latin America, Europe, Asia-Pacific, Middle East & Africa) – Size, Share, Outlook and Analysis of opportunities, 2020-2027

About Us:

Consistent market information is a global market intelligence and consulting organization that aims to help our plethora of clients achieve transformational growth by helping them make critical business decisions. Our head office is located in India, we have a sales office in the world financial capital in the United States, and sales consultants in the United Kingdom and Japan. Our clientele includes players from various industries in more than 57 countries around the world.

Follow us: LinkedIn | Twitter


[ad_2]

Leave A Reply

Your email address will not be published.